EXPERIMENTAL AND MOLECULAR MEDICINE
Scope & Guideline
Transforming insights into breakthroughs in clinical biochemistry.
Introduction
Aims and Scopes
- Molecular Mechanisms of Disease:
Focuses on the molecular pathways involved in various diseases, including cancer, metabolic disorders, and neurodegenerative diseases, providing insights into potential therapeutic targets. - Experimental Models and Techniques:
Utilizes diverse experimental models, including organoid systems, animal models, and advanced imaging techniques, to investigate disease mechanisms and test therapeutic interventions. - Translational Research:
Emphasizes the translation of laboratory findings into clinical applications, bridging the gap between basic science and clinical practice, particularly in oncology and regenerative medicine. - Immunology and Inflammation:
Explores the roles of immune responses and inflammation in disease progression and therapy, with a focus on therapeutic strategies that modulate immune pathways. - Genomics and Epigenetics:
Investigates the impact of genomic and epigenetic alterations on disease development and progression, employing cutting-edge sequencing technologies to elucidate complex biological processes. - Microbiome and Disease Interactions:
Examines the interactions between the microbiome and host physiology, particularly how these interactions influence disease states and therapeutic outcomes. - Advanced Therapeutics and Drug Development:
Covers innovative approaches in drug discovery, including the development of novel therapeutic agents, biomarker identification, and personalized medicine strategies.
Trending and Emerging
- Organoid Technology and Applications:
The use of organoids as models for disease research is rapidly expanding, allowing for more accurate studies of human physiology and disease mechanisms, as well as drug testing. - Targeted Cancer Therapies:
There is a growing focus on developing targeted therapies that exploit specific molecular pathways in cancer, reflecting advances in precision medicine. - RNA Biology and Therapeutics:
Research on the roles of non-coding RNAs, including microRNAs and long non-coding RNAs, is trending, with implications for cancer therapy and gene regulation. - Immunotherapy and Immune Modulation:
The exploration of novel immunotherapeutic strategies, including the manipulation of immune pathways and the development of immune checkpoint inhibitors, is gaining momentum. - Metabolic Reprogramming in Disease:
Research into how metabolic changes affect disease progression, particularly in cancer and metabolic disorders, is emerging as a critical area of study. - Microbiome Research and Health:
The investigation of the microbiome's role in health and disease is increasingly prominent, with implications for therapeutic interventions and understanding disease mechanisms. - Epigenetics and Disease:
The study of epigenetic modifications and their impact on gene expression and disease development is on the rise, highlighting the complexity of genetic regulation.
Declining or Waning
- Traditional Pharmacology:
Research focused on classical pharmacological approaches is less prevalent, as more emphasis is placed on targeted therapies and personalized medicine. - Basic Biochemistry:
While foundational biochemistry remains important, there is a noticeable shift towards more complex systems biology and molecular mechanisms, leading to a decline in studies centered solely on basic biochemical processes. - In vitro Cell Culture Studies:
The reliance on conventional in vitro studies has decreased, with a growing preference for more sophisticated models, such as organoids and 3D cultures, which better mimic in vivo conditions. - Animal Models of Disease:
The use of traditional animal models is declining in favor of more innovative and relevant models that can better replicate human disease mechanisms and responses to treatments. - Single Biomarker Studies:
Research focusing on single biomarkers is becoming less common as the field shifts towards integrative approaches that consider multiple factors and interactions within biological systems.
Similar Journals
MOLECULAR AND CELLULAR BIOLOGY
Pioneering Research in Cell Biology ExcellenceMOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.
Biochemistry Moscow-Supplement Series B-Biomedical Chemistry
Unveiling the Secrets of Life Through Cutting-Edge Biochemical Research.Biochemistry Moscow-Supplement Series B-Biomedical Chemistry, published by MAIK NAUKA-INTERPERIODICA, is a pivotal journal in the fields of biochemistry, clinical biochemistry, and molecular medicine. Established in 2008, the journal serves as a vital platform for researchers and professionals seeking to disseminate and access groundbreaking research in the biomedical sciences. With an ISSN of 1990-7508 and an E-ISSN of 1990-7516, the journal has been recognized in the Q4 quartile across various categories as of 2023, highlighting its emerging presence in the academic community despite a competitive landscape. Although currently not available as Open Access, the journal encompasses a broad spectrum of studies, ranging from theoretical analysis to practical applications in biomedical research. The journal's dedicated focus on advancing our understanding of biochemical principles positions it as an essential resource for students and professionals alike, enhancing its significance in the global scientific dialogue.
Physiology and Pharmacology
Innovating the understanding of physiology and pharmacology.Physiology and Pharmacology is a distinguished open access journal that has been disseminating high-quality research in the fields of physiology and pharmacology since its inception in 1997. Published by the Iranian Society of Physiology & Pharmacology, this journal offers a platform for scholars and practitioners to share innovative findings and advancements that contribute to the understanding of biological systems and drug action. With its ISSN 2476-5236 and E-ISSN 2476-5244, it ensures global reach and accessibility. The journal is positioned in the third quartile for Linguistics and Language and fourth quartile in both Pharmacology and Physiology categories according to Scopus rankings, reflecting a commitment to expanding knowledge within these interdisciplinary domains. Set within the academic landscape of Iran, the journal aims to bridge regional research with the international community, providing valuable insights into physiological processes and pharmacological developments. In light of its open access model, the Physiology and Pharmacology journal plays a crucial role in enhancing the visibility of research outcomes and fostering collaboration among researchers, professionals, and students on a global scale.
Cold Spring Harbor Perspectives in Medicine
Connecting Research and Practice in MedicineCold Spring Harbor Perspectives in Medicine is a premier academic journal published by the esteemed COLD SPRING HARBOR LAB PRESS that has become a crucial resource in the fields of Biochemistry, Genetics, and Medicine. With an impressive impact factor and consistently ranked in the Q1 quartile for both biochemistry and general medicine—as evidenced by its Scopus rankings of #21 and #26 respectively—this journal serves as an essential platform for disseminating high-quality research and comprehensive reviews from leading experts. Covering a convergence of knowledge spanning from 2011 through 2024, it plays a vital role in advancing the understanding of medical science. Researchers, professionals, and students alike benefit from Cold Spring Harbor Perspectives in Medicine, which offers a depth of insight into critical topics, emerging trends, and essential developments within the medical community. Join the conversation and contribute to the ongoing dialogue that drives innovation and excellence in medical research.
Autophagy
Bridging Fundamental Discoveries with Clinical InsightsAutophagy is a premier peer-reviewed journal published by Taylor & Francis, Inc. in the United States, focusing on advances in the fields of Cell Biology and Molecular Biology. With an impressive impact factor reflected in its Q1 ranking in both categories, Autophagy stands as a vital resource for researchers and professionals dedicated to understanding the intricate mechanisms of cellular degradation and recycling. The journal has been a cornerstone of scientific communication since its inception in 2005, continuing to flourish through 2024, fostering collaboration and innovation in the study of autophagic processes. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and its commitment to publishing high-quality, impactful research. By bridging fundamental research with clinical applications, Autophagy plays a crucial role in advancing our understanding of various diseases, making it an essential tool for scholars and practitioners in the biomedical field.
MOLECULES AND CELLS
Elevating Research, Shaping the Future of BiologyMOLECULES AND CELLS is a distinguished peer-reviewed journal published by the Korean Society for Molecular and Cellular Biology, dedicated to advancing the fields of Cell Biology, Molecular Biology, and Medicine. With a solid citation record and a robust reputation in its respective categories, the journal has achieved a ranking of Q2 in Cell Biology and Q1 in Miscellaneous Medicine as of 2023, demonstrating its impact and relevance to ongoing research in these vital disciplines. Although currently not open access, MOLECULES AND CELLS strives to provide a platform for innovative studies from diverse areas within molecular and cellular research, fostering collaboration among scientists worldwide. Established in 1996 and continuing to publish leading-edge research until 2024, this journal is essential for researchers, professionals, and students seeking to engage with the latest developments and insights in the life sciences.
Frontiers in Bioscience-Landmark
Elevating Knowledge in Biochemistry and BeyondFrontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.
Current Molecular Pharmacology
Exploring Innovations in Drug DiscoveryCurrent Molecular Pharmacology, published by Bentham Science Publishers, is a prominent journal focused on the dynamic fields of pharmacology, drug discovery, and molecular medicine. With an ISSN of 1874-4672 and an E-ISSN of 1874-4702, this journal aims to disseminate cutting-edge research and review articles that showcase innovative methodologies and groundbreaking findings from 2008 through 2024. Holding a respectable Q3 category ranking in Drug Discovery, Molecular Medicine, and Pharmacology for 2023, Current Molecular Pharmacology serves as an essential platform for both established researchers and emerging scholars to share their insights. The journal is indexed in Scopus with its relevant ranks catering to pharmacology and molecular biology, ensuring it reaches a wide array of professionals, researchers, and students in the field. As a contributor to advancing pharmacological sciences, this journal provides invaluable access to the latest advancements and fosters ongoing dialogue in molecular pharmacology, positioning itself as a key resource in the exploration of therapeutic agents and their interactions.
Byulleten Sibirskoy Meditsiny
Connecting Innovators in Biomedical SciencesByulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Bridging Research and Innovation in Life SciencesThe International Journal of Biochemistry & Cell Biology, published by Pergamon-Elsevier Science Ltd, stands as a pivotal resource in the fields of biochemistry and cell biology. With an ISSN of 1357-2725 and an E-ISSN of 1878-5875, this prestigious journal has been a key platform for disseminating cutting-edge research since its inception in 1995. The journal currently holds an impressive Q1 ranking in Biochemistry and a Q2 ranking in Cell Biology for the year 2023, reflecting its commitment to high-quality research and its influence within the scientific community. With a significant Scopus ranking of 94/438 in Biochemistry and 96/285 in Cell Biology, the journal plays a crucial role in advancing knowledge and fostering innovative approaches in these dynamic fields. Though it is not an open-access journal, the International Journal of Biochemistry & Cell Biology remains accessible to a wide audience, making it a vital resource for researchers, professionals, and students alike, who are eager to explore and contribute to the ongoing advancements in biochemistry and cell biology.